{"date":"2025-11-17","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7881-2025-11-17-1932-75ucws","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2025-11-17","time":"19:32:26","subject":"本公司受邀參加元大證券舉辦之興櫃前法人說明會","clause":"第9款","fact_date":"2025-11-17","cite_as":"公開資訊觀測站重大訊息：科明（7881），2025-11-17 19:32，「本公司受邀參加元大證券舉辦之興櫃前法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2025-11-17-1734-1o0sqgp","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2025-11-17","time":"17:34:38","subject":"本公司受邀參加證券櫃檯買賣中心舉辦之「櫃買市場業績發表會」","clause":"第12款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2025-11-17 17:34，「本公司受邀參加證券櫃檯買賣中心舉辦之「櫃買市場業績發表會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-11-17-1718-147qcwv","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-11-17","time":"17:18:45","subject":"公告本公司之法人董事改派代表人","clause":"第6款","fact_date":"2025-11-17","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-11-17 17:18，「公告本公司之法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-11-17-1640-1q01p5z","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-17","time":"16:40:16","subject":"公告本公司114年10月份自結應收帳款餘額及回收情形","clause":"第53款","fact_date":"2025-11-17","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-11-17 16:40，「公告本公司114年10月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2025-11-17-1526-1p5h1m5","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2025-11-17","time":"15:26:31","subject":"公告本公司召開法人說明會相關資訊","clause":"第12款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：生達（1720），2025-11-17 15:26，「公告本公司召開法人說明會相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2025-11-17-1503-pzpi5r","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2025-11-17","time":"15:03:41","subject":"智擎公司公告安能得（ONIVYDE）獲健康保險署核准納入一線合併療法治療轉移性胰腺癌之健保給付","clause":"第53款","fact_date":"2025-11-17","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2025-11-17 15:03，「智擎公司公告安能得（ONIVYDE）獲健康保險署核准納入一線合併療法治療轉移性胰腺癌之健保給付」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4161-2025-11-17-1421-1imw9og","company_id":"4161","company":"聿新科","market":"上櫃","industry":"生技醫療","date":"2025-11-17","time":"14:21:03","subject":"本公司受邀參加元大證券舉辦之法人說明會，就公司簡介、營運概況等事項進行說明。","clause":"第12款","fact_date":"2025-11-27","cite_as":"公開資訊觀測站重大訊息：聿新科（4161），2025-11-17 14:21，「本公司受邀參加元大證券舉辦之法人說明會，就公司簡介、營運概況等事項進行說明。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2025-11-17-1358-194aq5z","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2025-11-17","time":"13:58:12","subject":"本公司受邀參加福邦證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-11-18","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2025-11-17 13:58，「本公司受邀參加福邦證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-11-17-1317-1k21n1r","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-11-17","time":"13:17:11","subject":"公告本公司董事長訂定民國114年第3季盈餘之除息基準日","clause":"第14款","fact_date":"2025-11-17","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-11-17 13:17，「公告本公司董事長訂定民國114年第3季盈餘之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}